These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 19414339)

  • 1. Development of targeted therapy with paclitaxel incorporated into EGF-conjugated nanoparticles.
    Shimada T; Ueda M; Jinno H; Chiba N; Wada M; Watanabe J; Ishihara K; Kitagawa Y
    Anticancer Res; 2009 Apr; 29(4):1009-14. PubMed ID: 19414339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective targeting by preS1 domain of hepatitis B surface antigen conjugated with phosphorylcholine-based amphiphilic block copolymer micelles as a biocompatible, drug delivery carrier for treatment of human hepatocellular carcinoma with paclitaxel.
    Miyata R; Ueda M; Jinno H; Konno T; Ishihara K; Ando N; Kitagawa Y
    Int J Cancer; 2009 May; 124(10):2460-7. PubMed ID: 19173297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of an MPC-BMA co-polymer as a nanotransporter for paclitaxel.
    Wada M; Jinno H; Ueda M; Ikeda T; Kitajima M; Konno T; Watanabe J; Ishihara K
    Anticancer Res; 2007; 27(3B):1431-5. PubMed ID: 17595758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel immunosuppressant agents targeting activated lymphocytes by biocompatible MPC polymer conjugated with interleukin-2.
    Chiba N; Ueda M; Shimada T; Jinno H; Watanabe J; Ishihara K; Kitajima M
    Eur Surg Res; 2007; 39(2):103-10. PubMed ID: 17299267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrotropic oligomer-conjugated glycol chitosan as a carrier of paclitaxel: synthesis, characterization, and in vivo biodistribution.
    Saravanakumar G; Min KH; Min DS; Kim AY; Lee CM; Cho YW; Lee SC; Kim K; Jeong SY; Park K; Park JH; Kwon IC
    J Control Release; 2009 Dec; 140(3):210-7. PubMed ID: 19560497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
    Liang HF; Chen CT; Chen SC; Kulkarni AR; Chiu YL; Chen MC; Sung HW
    Biomaterials; 2006 Mar; 27(9):2051-9. PubMed ID: 16307794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced anti-glioblastoma efficacy by PTX-loaded PEGylated poly(ɛ-caprolactone) nanoparticles: In vitro and in vivo evaluation.
    Xin H; Chen L; Gu J; Ren X; Wei Z; Luo J; Chen Y; Jiang X; Sha X; Fang X
    Int J Pharm; 2010 Dec; 402(1-2):238-47. PubMed ID: 20934500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
    Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
    J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced solubility of paclitaxel using water-soluble and biocompatible 2-methacryloyloxyethyl phosphorylcholine polymers.
    Konno T; Watanabe J; Ishihara K
    J Biomed Mater Res A; 2003 May; 65(2):209-14. PubMed ID: 12734814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PEGylated poly(trimethylene carbonate) nanoparticles loaded with paclitaxel for the treatment of advanced glioma: in vitro and in vivo evaluation.
    Jiang X; Xin H; Sha X; Gu J; Jiang Y; Law K; Chen Y; Chen L; Wang X; Fang X
    Int J Pharm; 2011 Nov; 420(2):385-94. PubMed ID: 21920419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial distribution of intraperitoneally administrated paclitaxel nanoparticles solubilized with poly (2-methacryloxyethyl phosphorylcholine-co n-butyl methacrylate) in peritoneal metastatic nodules.
    Kamei T; Kitayama J; Yamaguchi H; Soma D; Emoto S; Konno T; Ishihara K; Ishigami H; Kaisaki S; Nagawa H
    Cancer Sci; 2011 Jan; 102(1):200-5. PubMed ID: 20942868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel.
    Liu J; Li H; Chen D; Jin X; Zhao X; Zhang C; Ping Q
    Drug Deliv; 2011 Apr; 18(3):181-9. PubMed ID: 20942638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of intravesical administration of paclitaxel solubilized with poly(2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate) in an orthotopic bladder cancer model.
    Tamura K; Kikuchi E; Konno T; Ishihara K; Matsumoto K; Miyajima A; Oya M
    BMC Cancer; 2015 Apr; 15():317. PubMed ID: 25928041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic((R))P85, an in vitro cell line and in vivo biodistribution studies on rat model.
    Shah N; Chaudhari K; Dantuluri P; Murthy RS; Das S
    J Drug Target; 2009 Aug; 17(7):533-42. PubMed ID: 19530913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
    Zhang L; Yao J; Zhou J; Wang T; Zhang Q
    Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F; Wang C; Lu Q; Zhao M; Ban FQ; Yu DH; Guan YY; Luan X; Liu YR; Chen HZ; Fang C
    Biomaterials; 2013 Aug; 34(26):6163-74. PubMed ID: 23706689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance.
    Patil Y; Sadhukha T; Ma L; Panyam J
    J Control Release; 2009 May; 136(1):21-9. PubMed ID: 19331851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follicle-stimulating hormone peptide can facilitate paclitaxel nanoparticles to target ovarian carcinoma in vivo.
    Zhang XY; Chen J; Zheng YF; Gao XL; Kang Y; Liu JC; Cheng MJ; Sun H; Xu CJ
    Cancer Res; 2009 Aug; 69(16):6506-14. PubMed ID: 19638590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.